Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
5.31
+0.33 (6.63%)
May 20, 2025, 4:00 PM - Market closed
Cogent Biosciences Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for Cogent Biosciences stock ranges from a low of $7.00 to a high of $21. The average analyst price target of $13.67 forecasts a 157.44% increase in the stock price over the next year.
Price Target: $13.67 (+157.44%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Cogent Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +125.99% | May 20, 2025 |
| Baird | Baird | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +31.83% | May 7, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $17 | Buy | Initiates | $17 | +220.15% | Mar 7, 2025 |
| Baird | Baird | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | +50.66% | Feb 27, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 26, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
39.96M
EPS This Year
-2.26
from -2.46
EPS Next Year
-1.92
from -2.26
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 119.5M | 640.9M | ||
| Avg | n/a | 40.0M | 212.8M | ||
| Low | n/a | n/a | 63.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 1,503.9% | ||
| Avg | - | - | 432.6% | ||
| Low | - | - | 59.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.72 | -1.46 | 1.18 | ||
| Avg | -2.26 | -1.92 | -0.92 | ||
| Low | -2.71 | -3.00 | -1.75 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.